Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prolyl oligopeptidase (POP), also known as prolyl endopeptidase (PREP), is a large cytosolic serine protease that specifically cleaves peptide bonds on the carboxyl side of proline residues in peptides shorter than 30 amino acids [1]. It is highly expressed in the brain and is involved in the maturation and degradation of neuropeptides such as substance P, neurotensin, and vasopressin [2]. Beyond its catalytic role, POP has been identified as a key modulator of alpha-synuclein aggregation and autophagy, making it a significant therapeutic target for Parkinson's disease and other neurodegenerative disorders [3]. While traditional drug discovery has focused on the enzyme's active site, recent research has highlighted an alternative allosteric site located within the β-propeller domain [4]. Targeting this allosteric site offers a novel mechanism to regulate POP's protein-protein interactions and enzymatic activity with potentially improved selectivity and reduced off-target effects compared to active-site inhibitors [2]. This approach is currently being explored to develop treatments for cognitive deficits and synucleinopathies [4]. The β-propeller domain acts as a gatekeeper for the active site, and allosteric ligands can influence the opening and closing of this domain [3]. Consequently, allosteric modulators of POP represent a promising class of compounds for precision medicine in neurology [4].
Allosteric modulation of enzyme activity and protein-protein interactions, specifically targeting the β-propeller domain to inhibit alpha-synuclein aggregation and regulate neuropeptide processing.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolyl oligopeptidase (POP) (POP).